International Journal of
Environmental Research
and Public Health
Article
The Validity and Reliability of the PHQ-9 and PHQ-2 on
Screening for Major Depression in Spanish Speaking
Immigrants in Chile: A Cross-Sectional Study
AntoniaErrazuriz1,* ,RodrigoBeltrán1,RafaelTorres1andAlvaroPassi-Solar2,3
1 DepartmentofPsychiatry,SchoolofMedicine,PontificiaUniversidadCatolicadeChile,
Santiago8330077,Chile
2 DepartmentofPublicHealth,SchoolofMedicine,PontificiaUniversidadCatolicadeChile,
Santiago8330077,Chile
3 ResearchDepartmentofEpidemiology,PublicHealthUniversityCollegeLondon,
LondonWC1E7HB,UK
* Correspondence:anerrazuriz@uc.cl
Abstract:Background:Thestudyaimedtoexplorethepsychometricpropertiesoftwoversionsof
thePatientHealthQuestionnaires(PHQ-9andPHQ-2)onscreeningforMajorDepressiveDisorder
(MDD)amongSpanish-speakingLatinAmericanadultimmigrantsinSantiago,andtoexplorefactors
associatedwithahigherriskofoccurrenceofMDDamongthem.Methods:Arepresentativesample
of897Spanish-speakingimmigrantscompletedthePHQ-9.TheCompositeInternationalDiagnostic
Interview(CIDI)wasemployedtoevaluateMDD.Internalconsistencyandstructuralvaliditywere
evaluatedusingCronbach’sαcoefficientandconfirmatoryfactoranalysis(CFA).Convergentvalidity
withthe7-itemGeneralAnxietyDisorderScale(GAD-7)wasassessedusingSpearman’scorrelations.
Citation:Errazuriz,A.;Beltrán,R.; Sensitivity,specificity,positivepredictivevalues,andareaunderthereceiveroperatingcharacteristic
Torres,R.;Passi-Solar,A.The (ROC)curvewerecalculatedfordifferentcut-offpoints. Logisticregressionanalysiswasusedto
ValidityandReliabilityofthe identifyfactorsassociatedwiththeriskofMDD.Results:Cronbach’sαcoefficientofthePHQ-9was
PHQ-9andPHQ-2onScreening
0.90;item-totalcorrelationcoefficientsrangedfrom0.61to0.76andcorrelationwiththeGAD-7was
forMajorDepressioninSpanish
moderate (r = 0.625; p < 0.001). CFA on three alternative models suggests a plausible fit in the
SpeakingImmigrantsinChile:A
overallsampleandamongtwoofthesubsamples:PeruviansandVenezuelans.Takingtheresults
Cross-SectionalStudy.Int.J.Environ.
ofCIDIasthegoldstandardforMDD,theareaundertheROCcurvewas0.91(95%confidence
Res.PublicHealth2022,19,13975.
interval(CI):0.83~1.0).Whenthecut-offscorewasequalto5,valuesofsensitivity,specificity,and
https://doi.org/10.3390/
ijerph192113975 Youden’s index were 0.85, 0.90, and 0.75, respectively. Multivariate logistic regression analyses
showedthattheinfluenceofhavingthreeormorechildren(OR=3.91,95%CI:1.20~12.81;p<0.05),
AcademicEditor:BálticaCabieses
residencyinChileofuptothreeyears(OR=1.79,95%CI:1.07~3.00;p<0.05),activedebt(OR=2.74,
Received:3September2022 95%CI:1.60~4.70;p<0.001),aone(OR=2.01,95%CI:1.03~3.94;p<0.05)andtwoormoreeventsof
Accepted:24October2022 adversityduringchildhood(OR=5.25,95%CI:1.93~14.3;p<0.01)ontheoccurrenceofMDDwas
Published:27October2022 statisticallysignificant.Reliability(α=0.62),convergent(r=0.534;p<0.01)andcriterion(AUC=0.85,
Publisher’sNote:MDPIstaysneutral 95%CI:0.67~1.00)validitycoefficientsofthePHQ-2wereweakerthanforthePHQ-9.Conclusions:
withregardtojurisdictionalclaimsin ThePHQ-2andthePHQ-9arereliableandvalidinstrumentsforuseasscreenersforMDDamong
publishedmapsandinstitutionalaffil- Spanish-speakingpopulationsofLatinAmerica.
iations.
Keywords:depression;patienthealthquestionnaire;CompositeInternationalDiagnosticInterview;
population-basedsample;immigrantmentalhealth
Copyright: © 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
1. Background
distributed under the terms and
MajorDepressiveDisorder(MDD)isoneofthemostprevalentmentalhealthcondi-
conditionsoftheCreativeCommons
tionsinthegeneralpopulation[1],globallyaffectinganestimated4.7%ofindividualsin
Attribution(CCBY)license(https://
thecommunity[2]. Itisalsothemostcommonpsychiatricconditioninpeoplewhodie
creativecommons.org/licenses/by/
4.0/).
Int.J.Environ.Res.PublicHealth2022,19,13975.https://doi.org/10.3390/ijerph192113975 https://www.mdpi.com/journal/ijerph
Int.J.Environ.Res.PublicHealth2022,19,13975 2of13
fromsuicide[3]andoneoftheleadingcausesofburden[4]. MDD,however,isfrequently
untreated,particularlyinlow-andmiddle-incomecountries[5].
Thenine-itemPatientHealthQuestionnaire(PHQ-9)isoneofthemostwidelyused
screeningquestionnairesforMDD[6]andhasbeentranslatedintomorethan80languages[7].
Itsaccuracyhasbeenshowntobegreaterthanunaidedcliniciandiagnoseswithmuch
highersensitivity(0.80)andspecificity(0.92)[8]thanthesensitivity(0.50)andspecificity
(0.81)ofprimarycareproviders’diagnoses[9].
TheSpanishversionofthePHQ-9[10]hasbeenvalidatedinsomeLatinAmerican
populations. Itspsychometricpropertiesandconvergentvaliditywithastructuredclin-
icalinterviewasareferencegoldstandardhavebeendocumentedinclinicalsettingsin
Argentina[11,12],Colombia[13],Peru[14],andChile[15,16]anditsfactorstructurehas
beenstudiedamongseveralnon-clinicalsubpopulations:collegestudentsinColombia[17],
Ecuador[18]andPeru[19],andteachers[20]andruralcommunitiesinMexico[21]. The
performanceofthefirsttwoitemsofthePHQ(i.e.,PHQ-2)versusallnineitemshasalso
been assessed in primary care in Colombia [22] and among non-clinical populations in
Chile[23]andMexico[21].
Chile has been increasingly receiving economic immigrants in the last decade. In
2017, the estimated number of immigrants was 700,000, representing 4.4% of the total
population[24]. Alargemajorityofimmigrants(76%)originatefromSpanish-speaking
LatinAmericancountries,withPeruvians,Colombians,andVenezuelansformingthefirst,
second,andthirdlargestgroups(50.4%ofallimmigrants[24]). Whilealowerprevalence
ofMDDamongimmigrantscomparedtothenative-bornpopulationhasbeendocumented
in high-income countries [25–28], evidence suggests that, in some cases, the migration
experiencemayhaveanegativeimpactonmentalhealth[29,30].
BecauseofthegrowthinthenumberofLatinAmericanimmigrantsarrivinginChile,
andthelayersofvulnerabilitytheyexperience[31],itisimportanttounderstandifthe
availablescreeningmeasuresforMDDarevalidtouseamongthem.
Toourknowledge,theSpanishversionofthePHQ-9hasnotbeenvalidatedinnon-
clinicalpopulationsofLatinAmericawithareferencegoldstandardandnostudieshave
validateditsscreeningcharacteristicsamongSpanish-speakingimmigrantsinChile. To
coverthisgap,wedesignedthepresentstudywhichanalysesthepsychometricproperties
ofthePHQ-9amongarepresentativesampleofnativeSpanish-speakingadultimmigrants
in Santiago, Chile. The primary aim focuses on the reliability of items (internal consis-
tency), the dimensionality (structural validity), and convergence with a reference gold
standardinidentifyingrespondentswithMDD(criterionvalidity). Secondaryaimsinclude
(i)identifyingfactorsassociatedwithahigherriskoftheoccurrenceofMDDintheSpanish-
speakingimmigrantpopulationinChile,and(ii)exploringthepsychometricpropertiesof
thePHQ-2amongthispopulation. Theresultsofthisstudywillprovideevidenceabout
thequalityofthisscreeningtoolforMDDforthisspecificimmigrantpopulationaswellas
informationabouttheprevalenceofdepressivesymptomsandassociatedfactorstoMDD
amongthem.
2. MaterialandMethods
2.1. Design
The Santiago Immigrant Wellbeing Study (STRING) is a population-based cross-
sectionalhouseholdmentalhealthsurveyof1115first-generationadultimmigrantsresiding
intheSantiagoMetropolitanRegion(RegiónMetropolitana;RM)ofChile. Thestudywas
prospectivelyregistered(ClinicalTrials.govIdentifier:NCT04114565;ISRCTN96875479)and
approvedbytheEthicsCommitteeoftheSchoolofMedicineofthePontificiaUniversidad
CatolicadeChile(No. 170519004). DatawascollectedbetweenAugustandOctober2019.
2.2. Participants
The sampling framework of the Chilean National Institute of Statistics was used.
Multi-stagerandomprobabilitysampling,comparabletothatofotherhouseholdsurvey
Int.J.Environ.Res.PublicHealth2022,19,13975 3of13
designsconductedindevelopingcountrieswasemployed[32]. Basedon(i)thenumberof
immigrantsrecordedintheRMinthe2017ChileanPopulationCensus[33],distributedin
120conglomerates(i.e.,clustersof200householdswithameannumberof9.2immigrants),
and (ii) the density of the immigrant population in the RM, the minimum sample size
to generate statistical inferences was set at 1104. The final sample was composed of
1115 participants, of which 1091 were interviewed in Spanish and 24 in Creole. To be
eligible,participantshadto: (i)beacommunity-residingadult(18+years),(ii)beableto
readandwrite,(iii)havebeenbornoutsideofChile(self-reportedandprovidingaNational
IDnumber),and(iv)havebeenresidinginChileforatleastsixmonths.
Thisstudyaimedtoexplorethepsychometricpropertiesofthenine-andtwo-item
PatientHealthQuestionnaires(i.e.,PHQ-9andPHQ-2)onscreeningfordepressionamong
thesubsampleofparticipantsoftheSTRINGstudyinterviewedinSpanishandbornin
Spanish-speakingLatinAmericancountries(n=897).
2.3. Measures
ThePHQ-9isanine-itemself-reportingquestionnairethatassessesthepresenceand
severityofdepressivesymptoms(i. anhedonia,ii. depressedmood,iii. sleepproblems,
iv. low energy, v. appetite changes, vi. low self-esteem, vii. concentration difficulty,
viii. psychomotoragitationorretardationandix. suicidalideation)inthelasttwoweeks
basedontheDSM-IVcriteriaforMDD.UsingaLikertscale,eachitemcanberatedfrom0
(notatall)to3(nearlyeveryday)withtotalscoresrangingfrom0to27. Fivecategories
ofsymptomseverityhavebeenproposed: 0–4(minimum),5–9(mild),10–14(moderate),
15–19(moderatetosevere),20–27(serious)[6]andcut-offscoresbetween8and11have
beenrecommendedforaprobablecaseofMDD[34]. Inthisstudy,theSpanishversionof
thequestionnairewasemployed[10]andadministeredface-to-face.
ThePHQ-2isanultra-briefversionofthePHQ-9whichincludesthefirsttwoitems
(i. anhedonia,ii. depressedmood). Totalscoresrangefrom0to6andtherecommended
cut-offpointforadministeringthefullPHQ-9orconductingaclinicalinterviewtoassess
forMDDisascoreof3orgreater[35].
Symptomsofanxietyduringthe2weeksprecedingtheinterviewwereassessedusing
theSpanishversionofthe7-itemGeneralAnxietyDisorder(GAD–7)scale[36]. DSM-IV
MDD in the last 12 months was assessed using two modules of the WHO Composite
InternationalDiagnosticInterview(WHO-CIDI)(CAPI3.0): depression,andmania[37].
TheWHO-CIDIisagoldstandardforMDDdiagnosiswhichhasbeenusedextensively
in major epidemiological studies in Argentina [38], Chile [39,40], Colombia [5,41–47],
Guatemala[48],Mexico[5,49–51]andPeru[5,52].
ChildhoodtraumawasmeasuredusingtheSpanish-translatedversionoftheAdverse
ChildhoodExperiencesInternationalQuestionnaire(ACE-IQ)[53]andcodedinto0,1,or
2ormoreadverseevents.
Participants’gender,age,countryofbirth,numberofchildrenagedunder18years,
durationofresidencyinChile(upto3years;morethan3years),highesteducationallevel
(primary: 8 years or less; secondary: 9 to 12 years; or higher: >12 years), employment
status(unemployedoreconomicallyinactiveversusemployed),activedebtstatus(withor
without)wasrecorded.
2.4. StatisticalAnalysis
TocharacterizetherepresentativeimmigrantpopulationofSantiago,samplingweights
assignedtothesubjectswereapplied. Fordescriptivestatistics,means,standarddeviations,
andfrequencieswerecalculatedfordemographicandeconomicfactorsandforthenumber
ofchildhoodadversityevents.
The normality distribution was tested using the Kolmogorov-Smirnov test. When
variableswerenotfoundtohaveanormaldistribution,Spearman’sRhowasused. For
reliability, the internal consistency of the PHQ-9 was assessed using Cronbach’s alpha
(α)coefficientsanditem-totalcorrelations. ForthePHQ-2,Spearman–Browncoefficients
Int.J.Environ.Res.PublicHealth2022,19,13975 4of13
werecalculatedasanadditionalmeasureofreliability. Alphacoefficientsabove0.70–0.80
were considered indicative of good internal consistency [54]. Correlations above 0.90,
between0.70and0.90,andbetween0.50and0.70wereconsideredveryhigh,high,and
moderate,respectively[55].
ToinvestigatethefactorstructureofthePHQ-9items,Confirmatoryfactoranalysis
(CFA)withthemaximum-likelihoodprocedurewasconducted. UsingCFA,threealterna-
tivemodelsofthestructureofthePHQ-9weretestedtounderstandthedimensionalityof
thescale: (i)theoriginalone-factormodelhypothesizedbyKroenke[6],(ii)atwo-factor
model suggested by Krause [56] where three items (i.e., ‘sleep problems’, ‘low energy’
and‘appetitechanges’)areloadedonasomaticfactor,and(iii)anothertwo-factormodel
derivedbyRichardsonandRichard[57]wherethesomaticfactoralsoincludes‘concentra-
tiondifficulties’and‘psychomotoragitation/retardation’(FigureS1). Inadditiontothe
chi-square(χ2)anditsdegreesoffreedom(df),modelswerecomparedusingthefollowing
threemodelfitindicesandtheircriteria: (i)therobustcomparativefitindex(CFI)witha
valuegreaterthan0.95indicatingagoodmodelfitandvalueslargerthan0.90indicatinga
plausiblemodelfit[58],(ii)therobustrootmeansquareerrorofapproximation(RMSEA)
and its 90% confidence interval with a value lower than 0.05 indicating a good fit and
valueslowerthan0.08indicatingaplausiblefit[59],and(iii)thestandardizedrootmean
squareresidual(SRMR)withvalueslessthan0.05indicatingagoodfitwellandvalues
lowerthan0.08indicatingaplausiblefit[60]. Amodelwasconsideredtofitwelliftwoof
thethreecriteriaweremet.
The convergent validity of the PHQ-2 and PHQ-9 was assessed using Spearman’s
correlationswiththeGAD-7. ToassesstheaccuracyofbothformsofthePHQasscreening
toolscomparedtotheCIDI,thereceiveroperatingcharacteristics(ROC)andAUCwere
analyzed. Theoptimumcut-offpointforthePHQ-9wasdeterminedconsideringvalidity
indices: sensitivity(Se),specificity(Sp),positiveandnegativepredictivevalue(PPV;NPV),
Youden’sindex,positiveandnegativelikelihoodratios(LR),andROCcurve/AUCanalysis.
Twoadditionalindiceswereused: clinicallyrelevantruleinaccuracyasestimatedbythe
clinical utility index positive (CUI+) and rule out accuracy as estimated by the clinical
utilityindexnegative(CUI)[61].
Toevaluatetheassociationbetweendemographic,economic,andadversitycharac-
teristicsandatotalPHQ-9totalscoreoverthedefinedoptimumcut-offpoint,age,and
gender-adjustedlogisticregressionanalyseswereconducted.
The statistical analysis, excluding CFA, was performed using SPSS for Windows,
version20.0(IBMCorp,Armonk,NY,USA).CFAwasconductedusingR3.5.1software
(The R Foundation for Statistical Computing, Vienna, Austria). A p-value < 0.05 was
consideredsignificant.
3. Results
3.1. SampleCharacteristics
Table 1 illustrates the sociodemographic, economic, and childhood adversity char-
acteristics of the final sample (n = 897). The mean age of participants was 36.6 years
(SD=11.5);478(53.6%)hadnochildrenundertheageof18,217(22.7%)hadone,144(16.2%)
hadtwoand55(7.5%)hadthreeormorechildren. Therewere509women(53.8%)and
388men(46.2%);94respondentshadbeenborninColombia(13.2%),333inPeru(26.6%),
375inVenezuela(33.3%),and95(26.9%)inotherSpanish-speakingLatinAmericancoun-
tries(Bolivia,Cuba,DominicanRepublic,Ecuador,andMexico);444(50.3%)participants
hadmigratedinthelastthreeyearsand453(49.7%)morethanthreeyearsago.
Fewparticipants(7.6%)wereunemployedoreconomicallyinactive;72(7.2%)respon-
dentshad≤8yearsofeducation,351(41.6%)hadbetween9and12,and471(51.2%)had
morethan12years,and201(22.4%)heldatleastonedebtatthemomentoftheinterview.
Noeventsofchildhoodadversitywerereportedbymostparticipants(68.6%),oneevent
wasreportedby15.7%,andtwoormoreeventsby15.7%ofparticipants.
Int.J.Environ.Res.PublicHealth2022,19,13975 5of13
Table1.Sociodemographic,economic,andchildhoodtraumacharacteristicsofparticipants(n=897).
n (%)
Sociodemographic
Gender
Female 509 (53.8)
Male 388 (46.2)
Age
18to27years 199 (25.6)
28to37years 349 (39.4)
38to47years 184 (17.8)
48or+years 165 (17.2)
Numberofchildren(<18)
0 478 (53.6)
1 217 (22.7)
2 144 (16.2)
3ormore 55 (7.5)
Countryofbirth
Colombia 94 (13.2)
Peru 333 (26.6)
Venezuela 375 (33.3)
OtherLA 95 (26.9)
DurationofresidencyinChile
Upto3years 444 (50.3)
Morethan3years 453 (49.7)
Economic
Education
Primary(≤8yrs) 72 (7.2)
Secondary(9–12yrs) 351 (41.6)
Higher(>12yrs) 471 (51.2)
Employed,yes(ref:unemployed/inactive) 823 (92.4)
Debtstatus,with(ref:without) 201 (22.4)
Childhoodtrauma
Eventsofadversity
0 639 (68.6)
1 137 (15.7)
2ormore 121 (15.7)
Note:Numberofcasesunweightedand%weighted;LatinAmerica(LA).
Only34(4.5%)participantsscoredabovethePHQ-9mostcommoncut-offscore(≥10),
42(4.6%)respondentsabovetherecommendedcut-offscoreforthePHQ-2(≥3),andonly
6(0.7%)participantsmetthecriteriaforDSM-IVMDDinthelast12months(Table2).Results
forspecificimmigrantgroupsshowedtheproportionofPHQ-9totalscores≥10rangedfrom
1.7%amongVenezuelansto7.1%amongPeruvians,andtheproportionofPHQ-2scores≥3
rangedfrom1.4%amongotherLatinAmericansto8.1%amongColombians(TableS1).
Table2.DistributionofPHQscoresand12-month-CIDIMajorDepressiveDisorder(n=897).
Questionnaire CIDI
DepressiveSymptomsSeverity n (%) Negative Positive
PHQ-9
None(0–4) 790 (86.8) 789 1
Mild(5–9) 73 (8.6) 69 4
Moderate(10–14) 19 (2.3) 19 0
Severe(≥15) 15 (2.2) 14 1
PHQ-2
Minimum(0–2) 855 (95.4) 851 4
Mild(≥3) 42 (4.6) 40 2
Total 897 (100.0) 891 6
Note:Numberofcasesunweightedand%weighted.CompositeInternationalDiagnosticInterview(CIDI);9-item
PatientHealthQuestionnaire(PHQ-9);2-itemPatientHealthQuestionnaire(PHQ-2).
Int.J.Environ.Res.PublicHealth2022,19,13975 6of13
3.2. Reliability
Values of the reliability coefficient Cronbach’s α for the PHQ-9 and PHQ-2 were
0.904 and 0.746, indicating acceptable reliability. For both PHQ forms, corrected item-
total correlations ranged from moderate to high (0.604–0.760), and the internal consis-
tencyofthePHQ-9wouldnothaveimprovedwiththedeletionoflaterscaleitems. The
Spearman–Brownbetween-itemcorrelationcoefficientforthePHQ-2wassignificantbut
moderate(r=0.62;p<0.001)(TableS2). ThereliabilityofthePHQ-9wasacceptableacross
immigrantgroups(allα>0.7)andcorrecteditem-totalcorrelationsrangedfromlowto
high (0.451–0.845), (Table S3). The reliability of the PHQ-2 was only acceptable for the
PeruvianandotherLatinAmericansubsamples(allα>0.7andr>0.70;p<0.001)(TableS4).
3.3. FactorStructure
Confirmatory factor analysis (CFA) on three alternative models was performed: a
one-factormodel(model1)andtwotwo-factormodels(models2aand2b). Thegoodness
of fit indices suggest a plausible fit for the three models for the overall sample and the
Peruviansubsampleandformodel2afortheVenezuelansubsample,withCFIvalueslarger
than0.90andSRMSvalueslowerthan0.08. ThegoodnessoffitindicesfortheColombian
andtheotherLatinAmericansubsamplesdemonstrateinadequatefitofallthreemodels
(TableS5).Overallresultsfromthetwo-factormodelsshowedthatthesomaticandaffective
factorswerehighlycorrelated(allp<0.001).
3.4. ConvergentValidity
Intheoverallsample,thePHQ-9wasmoderatelyandpositivelycorrelatedwiththe
GAD-7 (r = 0.625; p < 0.001), which measures anxiety symptoms. Correlation between
PHQ-2andGAD-7scoreswasweaker,butsignificant(r=0.534;p<0.01). Acrossimmi-
grantgroups,correlationsbetweentheGAD-7andthePHQ-9andPHQ-2weremoderate
(allr≥0.60;p<0.001)andlow-to-moderate(allr≥0.44;p<0.001),respectively.Convergent
validitywas,therefore,satisfiedforbothformsofthePHQwithoursample(TableS6).
3.5. CriterionValidity
TheperformanceofthetwoversionsofthePHQwasexaminedagainstthediagnosisof
MDDaccordingtotheWHO-CIDIasagoldstandard. ThemeanPHQ-9andPHQ-2scores
forparticipantsmeetingthecriteriaforMDDwere9.14(SD=5.36)and2.19(SD=1.39),
respectively,whereasthemeanscoresforparticipantsnotmeetingthecriteriaforMDD
were1.71(SD=3.68)and0.38(SD=0.98),respectively.
Table3summarizestheoperatingcharacteristicsofthePHQ-9andPHQ-2atdifferent
cut-offpointsfordiagnosingMDDagainsttheWHO-CIDI.ForthePHQ-9,thecut-offof
5yieldedthebestdiagnosticperformanceintermsofmaximizingsensitivityandspecificity
valuesbasedontheYoudenJindex(sensitivity=85%;specificity90%).Despitetheexcellent
rule-outaccuracy(CU−=0.90)andNPV(NPV=1.00)forthiscut-offscore,negativeand
positivelikelihoodratiosweremoderate(LR+=8.73; LR−=0.17)andPPVandrule-in
accuracywereverypoor(PPV=0.06;CUI+=0.05). TheROCcurveanalysisestimatedthe
areaunderthecurve(AUC)forthePHQ-9was0.91(95%CI:0.83–1.00)(Figure1),which
accountsforoutstandingclassificationaccuracy.
ForthePHQ-2,optimaldiagnosticperformancewasachievedatacut-offscoreof1,
whichbestbalancessensitivityandspecificity(sensitivity=73%;specificity89%). Despite
the high NPV (NPV = 1.00) and excellent rule-out accuracy (CU− = 0.89) for this cut-
off score, likelihood ratios were moderate (LR+ = 6.58; LR− = 0.30) and PPV and rule-
in accuracy were very poor (PPV = 0.04; CUI+ = 0.89). The AUC of PHQ-2 was 0.85
(95%CI:0.67–1.00)whichaccountsforexcellentaccuracy[62].
Int.J.Environ.Res.PublicHealth2022,19,13975 7of13
Figure1.Receptoroperatingcharacteristics(ROC)curvesofthePHQ-9andPHQ-2comparedwith
theCompositeInternationalDiagnosticInterviewasareferencestandardforMDD.
Table3.PerformanceofPHQ-9andPHQ-2cut-offscoresindetectingmajordepressivedisorder.
Youden’s
Scale Cut-Point Sensitivity Specificity PPV NPV CUI+ CUI− LR+ LR−
Index(J)
PHQ-9
PHQ≥1 0.85 0.72 0.57 0.02 1.00 0.02 0.72 3.07 0.21
PHQ≥2 0.85 0.80 0.64 0.03 1.00 0.02 0.79 4.14 0.19
PHQ≥3 0.85 0.84 0.69 0.04 1.00 0.03 0.84 5.43 0.18
PHQ≥4 0.85 0.87 0.72 0.04 1.00 0.04 0.87 6.65 0.18
PHQ≥5 0.85 0.90 0.75 0.06 1.00 0.05 0.90 8.73 0.17
PHQ≥6 0.73 0.92 0.65 0.06 1.00 0.04 0.92 9.51 0.29
PHQ≥7 0.73 0.93 0.66 0.07 1.00 0.05 0.93 10.81 0.29
PHQ≥8 0.49 0.95 0.43 0.06 1.00 0.03 0.94 8.92 0.54
PHQ≥9 0.22 0.96 0.17 0.03 0.99 0.01 0.95 4.89 0.82
PHQ≥10a 0.22 0.96 0.18 0.04 0.99 0.01 0.96 5.96 0.81
PHQ≥11 0.22 0.97 0.19 0.05 0.99 0.01 0.97 7.59 0.81
PHQ≥12 0.22 0.97 0.19 0.05 0.99 0.01 0.97 7.59 0.81
PHQ≥13 0.22 0.97 0.19 0.05 0.99 0.01 0.97 7.80 0.81
PHQ≥14 0.22 0.98 0.20 0.06 0.99 0.01 0.97 10.27 0.80
PHQ≥15 0.22 0.99 0.21 0.14 0.99 0.03 0.99 24.1 0.79
PHQ-2
PHQ≥1 0.73 0.89 0.62 0.04 1.00 0.03 0.89 6.58 0.30
PHQ≥2 0.31 0.96 0.26 0.04 1.00 0.01 0.95 7.00 0.72
PHQ≥3b 0.31 0.98 0.29 0.08 1.00 0.03 0.97 13.76 0.71
Note:Clinicalutilityindexpositive(CUI+);Clinicalutilityindexnegative(CUI−);LikelihoodRatiopositive(LR+);
LikelihoodRationegative(LR−);NegativePredictiveValue(NPV);9-itemPatientHealthQuestionnaire(PHQ-9);
2-itemPatientHealthQuestionnaire(PHQ-2);PositivePredictiveValue(PPV).aAcut-offof10isrecommended
forthePHQ-9[6].bAcut-offof3isrecommendedforthePHQ-2[63].
3.6. VariablesAssociatedwithPHQ-9ScoresovertheOptimalCut-OffScore
AspresentedinTable4,atotalPHQ-9scoreovertheoptimalcut-offscore(i.e.,≥5)
wasstronglyassociatedwiththeexperienceofadversityduringchildhood. Comparedto
participantsreportingnochildhoodadversity,thosereportingoneortwoormoreeventsof
adversityweretwice(OR2.01,95%CI1.03–3.94)andfivetimes(OR5.25,95%CI1.93–14.34)
morelikelytoscore≥5inthePHQ-9,respectively. APHQ-9score≥5wasalsoassociated
Int.J.Environ.Res.PublicHealth2022,19,13975 8of13
withlengthofresidency,activedebt,andthenumberofchildren. Theoddsofreporting
ascoreabovethecut-offwerehigheramongthosewhohadimmigratedinthelastthree
years(OR1.79,95%CI1.07–3.00)versusthosewhohadbeenresidinginChileforover
three years, among those reporting active debt (OR 2.74, 95% CI 1.07–3.00) and among
thosewiththreeormorechildren(OR3.91,95%CI1.20–12.81).
Table4.VariablesindependentlyassociatedwithPHQ-9≥5withrespectiveadjustedoddsratios,
95%confidenceintervals,andp-values.
PHQ-9≥5
Factor OR 95%CI p-Value
Sociodemographic
Gendera
Male 1
Female 1.33 0.54to3.30 0.541
Agegroupb
18–27 1
28–37 0.63 0.37to1.06 0.083
38–47 0.63 0.30to1.35 0.240
≥48 0.91 0.48to1.71 0.762
Numberofchildren(<18)
0 1
1 1.62 0.89to2.95 0.117
2 1.54 0.72to3.30 0.265
3ormore 3.91 1.20to12.81 0.027
Countryofbirthc
Venezuela 1
Colombia 0.85 0.32to2.24 0.743
Perú 1.47 0.77to2.82 0.247
OtherLA 1.00 0.25to4.04 0.998
Durationofresidencyc
>3yrs 1
≤3yrs 1.79 1.07to3.00 0.029
Economic
Educationc
Higher(>12yrs) 1
Secondary(9–12yrs) 1.94 0.74to5.09 0.181
Primary(≤8yrs) 2.41 1.01to5.75 0.053
Currentlyholdingdebtc
No 1
Yes 2.74 1.60to4.70 <0.001
ChildhoodAdversity
Events(no.)c
0 1
1 2.01 1.03to3.94 0.045
≥2 5.25 1.93to14.34 0.002
aAdjustedbyageinyears.bAdjustedbygender.cAdjustedbyageinyearsandgender.
4. Discussion
ThepresentstudyisthefirsttoanalyzethepsychometricpropertiesofthePHQ-9and
PHQ-2inarepresentativesampleofSpanish-speakingadultimmigrantsinChile.Itsresults
expandtheevidenceofthevalidity,reliability,andaccuracyofbothversionsofthePHQto
aspecificnon-clinicalpopulationandcontributetotheliteratureabouttheprevalenceof
depressiveandanxietysymptomsandassociatedfactorsamongeconomicimmigrants.
ConsistentwithfindingsfromavailableprimarycarestudiesinChile[15,16,64,65],
goodinternalconsistencyofthePHQ-9intheoverallsampleandacrossimmigrantgroups
wasdemonstrated. Asexpected[66],thecorrelationbetweenthePHQ-9withtheGAD-
7wassignificantbutmoderateindicatingconvergentvalidityandsupportingthegrowing
bodyofliteratureaboutthecoexistenceandcomorbidityofdepressionandanxiety[67,68].
Int.J.Environ.Res.PublicHealth2022,19,13975 9of13
ContrarytoLatinAmericanvalidationstudiesofthePHQ-9amongclinical[16,66,69]
andnon-clinicalpopulations[17,19–21],whichhavedemonstratedagoodfitforbothone-
and two-factor solutions using confirmatory factor analysis, the goodness of fit indices
forthethreemodelstestedinthisstudyonlyindicateaplausiblefitintheoverallsample
andintwoofthefoursubsamples: PeruviansandVenezuelans. SomestudiesintheUS
havereportedapoorfitofthePHQ-9amongHispanicparticipants[70]butthepatternofa
plausiblefitacrossmodelsintheoverallsampleandaninadequatefitintheColombian
andotherLatinAmericansubsamplesobservedinthisstudyindicatetheneedtoexpand
research about the structure of the Spanish version of the PHQ-9 among non-clinical
populationsinLatinAmerica.
The PHQ-9 demonstrated high diagnostic accuracy and adequate sensibility and
specificityvalues,comparabletothosereportedinstudiesconductedinclinicalpopulations
in Chile using the CIDI as a gold standard [15,16]. As expected of a screener for a low
prevalencecondition,itperformedbetteratcorrectlyidentifyingindividualswithoutMDD
thanatconfirmingthepresenceofMDD,withnegative(NPV)andpositive(PPV)predictive
valuesforscoresbetween5and10intherangeof0.99–1.00and0.06–0.04,respectively. The
lowPPVsuggeststhatratherthanindicateaprobableMDDdiagnosis,ahighPHQ-9score
shouldberegardedasanindicationoftheneedforamorethoroughevaluation.
TheoptimalPHQ-9cut-offscorefordetectingMDDinthepresentstudywas≥5. This
scoreislowerthantheoriginalcut-offscore(≥10)[6]. Itisalsolowerthanreportedina
recentindividualparticipantdatameta-analysis(IPDMA)basedondatafrom100studies
whichconcludedthatacut-offscoreof≥8maximizedcombinedsensitivityandspecificity
forfullystructuredreferencestandards[71]. However,thecomparisonofthesevaluesis
limitedconsideringthequestionnairewasoriginallydevelopedusingdatafromprimary
care[6],andthenumberofstudiesfromnon-clinicalsamplesincludedintherecentmeta-
analysisislow(15%)[71].
Across parameters and subsamples, the PHQ-9 demonstrated better performance
thanthePHQ-2: higherinternalconsistency,strongerconvergentvaliditywiththeGAD-7,
betteraccuracywithregardtoagoldstandard,andhighersensitivityandspecificityfor
theproposedcut-offscores. However,takingintoaccountthebrevityofthePHQ-2andin
consistencywithfindingsfromstudiesamongclinical[22]andnon-clinical[21]populations
inLatinAmerica,resultsfromthisstudysuggestitsperformanceisacceptable.
Findingsfromthisstudysuggestthattheprevalenceofdepressivesymptomsand
MDD among and across Spanish-speaking immigrant groups is lower than among the
nativepopulationofChileandotherSpanish-speakingLatinAmericancountries,inde-
pendentoftheassessmentmethodused. Resultsfromgeneralpopulationstudiesusing
structuredclinicalinterviewsinChile[39,40,72],Colombia[5,42,43],andPeru[73]have
consistently reported a higher prevalence of MDD than observed in the present study.
Results from a general population study conducted in Chile using the PHQ-9 [23] also
reportahigherprevalenceofMDDthanreportedinthecurrentstudy. Thislowerriskfor
MDDrepresentsamentalhealthadvantagesimilartothatobservedamongfirst-generation
immigrantsfromLatinAmericaintheUnitedStates[74]andmaypartlybeexplainedby
theirhighlaborforceparticipationandlowlevelofexposuretoadversityduringchildhood.
FourfactorspredictedanincreasedriskofMDDamongimmigrants: thenumberof
children(≤18yrs),shortlengthofresidencyinChile(≤3yrs),activedebt,andexposureto
childhoodadversity. Contrarytoevidencesuggestingthatanincreaseinthelengthofresi-
dencyinthehostcountryisassociatedwithahigherriskofMDDamongimmigrants[75],
theriskofMDDinthisimmigrantpopulationwasnotpredictedbyalongerdurationof
residency. Thislackoffindingmayberelatedto(i)thesmallproportionofparticipants
whohavebeenexposedtotheprolongedeffectsofmigration(only12%havebeenresiding
inChileforover10years),or(ii)thecharacteristicsoftheacculturationprocessshaped
by high levels of cultural contiguity between Chile and other Latin American Spanish-
speakingcountriesatthelinguistic,religious,andethniclevel. Findingsfromthisstudy
supportthewell-establishedrelationshipsbetweenunsecureddebtandmentalhealth[76]
Int.J.Environ.Res.PublicHealth2022,19,13975 10of13
and between adversity during childhood [77], having three or more children [78], and
depressioninadulthood.
Severallimitationsofthisstudyshouldbeacknowledged. First,thegeneralizability
ofthefindingsregardingthepsychometricpropertiesofbothversionsofthePHQtonon-
nativeSpanish-speakingimmigrantsmaybelimited.Second,thegeneralizabilityregarding
theprevalenceofdepressivesymptomsandMDDandassociatedfactorstonon-economic
migrants,migrantsfromhigh-incomecountries,fromoutsidetheLatinAmericanregion,or
refugeesmaybelimitedbecauseofdifferentialexposuretostressthroughoutthemigration
process. Replicationwithmoreheterogeneoussamplesofimmigrantssuchasindividuals
withalongerdurationofresidencyinChile,withclinicalconditions,orserviceusersis
thusneeded.
5. Conclusions
FindingsfromthepresentstudyindicatethatboththePHQ-2andPHQ-9arepsycho-
metricallysoundmeasuresofdepressionforuseamongSpanish-speakingpopulationsin
LatinAmerica. Theseresultsaddtotheevidencethattheyarebrief,easytouse,andvalid
depressionmeasuresforuseinclinicalandnon-clinicalsettings.
Supplementary Materials: The following supporting information can be downloaded at: https:
//www.mdpi.com/article/10.3390/ijerph192113975/s1,FigureS1. TestedmodelsoftheSpanish
versionofPHQ-9;TableS1.DistributionofPHQscoresand12month-CIDIMajorDepressiveDisorder
byimmigrantgroup;TableS2.InternalconsistencyoftheChileanversionofthePHQ-9andPHQ-2
(n=897);TableS3. InternalconsistencyoftheChileanversionofthePHQ-9byimmigrantgroup;
TableS4. InternalconsistencyoftheChileanversionofthePHQ-2byimmigrantgroup;TableS5.
GoodnessoffitindicesforPHQ-9factormodelsbyimmigrantgroup;TableS6.Convergentvalidity
coefficientsofthePHQ-9andPHQ-2byimmigrantgroup.
AuthorContributions:Conceptualization,A.E.;Datacuration,A.E.;Fundingacquisition,A.E.;Method-
ology,A.E.,R.B.andA.P.-S.;Projectadministration,A.E.;Supervision,A.E.andR.T.;Writing—original
draft,A.E.;Writing—reviewandediting,A.E.Allauthorshavereadandagreedtothepublished
versionofthemanuscript.
Funding:ThisresearchwasfundedbyAgenciaNacionaldeInvestigaciónyDesarrollo,grantnumber
FONDECYT11170828.
InstitutionalReviewBoardStatement: ThestudywasapprovedbytheEthicsCommitteeofthe
SchoolofMedicineofthePontificiaUniversidadCatolicadeChileon10January2018(No.170519004).
Informed Consent Statement: Informed consent was obtained from all subjects involved in the
studyatthestartoftheinterview.
DataAvailabilityStatement: Thedatasetsgeneratedduringand/oranalysedduringthecurrent
studyareavailablefromthecorrespondingauthoronreasonablerequest.
ConflictsofInterest:Theauthorsdeclarenoconflictofinterest.
References
1. Kessler,R.C.;McGonagle,K.A.;Zhao,S.;Nelson,C.B.;Hughes,M.;Eshleman,S.;Wittchen,H.U.;Kendler,K.S.Lifetimeand
12-monthprevalenceofDSM-III-RpsychiatricdisordersintheUnitedStates.ResultsfromtheNationalComorbiditySurvey.
Arch.Gen.Psychiatry1994,51,8–19.[CrossRef][PubMed]
2. Ferrari,A.J.;Somerville,A.J.;Baxter,A.J.;Norman,R.;Patten,S.B.;Vos,T.;Whiteford,H.A.Globalvariationintheprevalenceand
incidenceofmajordepressivedisorder:Asystematicreviewoftheepidemiologicalliterature.Psychol.Med.2013,43,471–481.
[CrossRef][PubMed]
3. Hawton,K.;vanHeeringen,K.Suicide.Lancet2009,373,1372–1381.[CrossRef]
4. GBD2019MentalDisordersCollaborators.Global,regional,andnationalburdenof12mentaldisordersin204countriesand
territories,1990–2019: AsystematicanalysisfortheGlobalBurdenofDiseaseStudy2019. LancetPsychiatry2022,9,137–150.
[CrossRef]
5. Bromet,E.;Andrade,L.;Bruffaerts,R.;Williams,D.MajorDepressiveDisorder.InMentalDisordersAroundtheWorld:Factsand
FiguresfromtheWHOWorldMentalHealthSurveys;Scott,K.M.,deJonge,P.,Stein,D.J.,Kessler,R.C.,Eds.;CambridgeUniversity
Press:Cambridge,UK,2018;pp.41–56.
Int.J.Environ.Res.PublicHealth2022,19,13975 11of13
6. Kroenke,K.;Spitzer,R.L.;Williams,J.B.ThePHQ-9:Validityofabriefdepressionseveritymeasure.J.Gen.Intern.Med.2001,16,
606–613.[CrossRef]
7. Kroenke,K.Enhancingtheclinicalutilityofdepressionscreening.Can.Med.Assoc.J.2012,184,281.[CrossRef]
8. Gilbody,S.;Richards,D.;Brealey,S.;Hewitt,C.ScreeningfordepressioninmedicalsettingswiththePatientHealthQuestionnaire
(PHQ):Adiagnosticmeta-analysis.J.Gen.Intern.Med.2007,22,1596–1602.[CrossRef]
9. Mitchell,A.J.;Vaze,A.;Rao,S.Clinicaldiagnosisofdepressioninprimarycare: Ameta-analysis. Lancet2009,374,609–619.
[CrossRef]
10. Diez-Quevedo, C.; Rangil, T.; Sanchez-Planell, L.; Kroenke, K.; Spitzer, R.L. Validation and Utility of the Patient Health
QuestionnaireinDiagnosingMentalDisordersin1003GeneralHospitalSpanishInpatients.Psychosom.Med.2001,63,679–686.
[CrossRef]
11. Daray,F.M.;Hunter,F.;Anastasia,A.;Fornaro,M.PsychometricpropertiesofthePatientHealthQuestionnairenine-itemversion
(PHQ-9)foruseamonghospitalizednon-psychiatricmedicalpatients.Gen.Hosp.Psychiatry2019,61,69–75.[CrossRef]
12. Urtasun,M.;Daray,F.M.;Teti,G.L.;Coppolillo,F.;Herlax,G.;Saba,G.;Rubinstein,A.;Araya,R.;Irazola,V.Validationand
calibrationofthepatienthealthquestionnaire(PHQ-9)inArgentina.BMCPsychiatry2019,19,291.[CrossRef][PubMed]
13. Cassiani-Miranda,C.A.;Cuadros-Cruz,A.K.;Torres-Pinzón,H.;Scoppetta,O.;Pinzón-Tarrazona,J.H.;López-Fuentes,W.Y.;Paez,
A.;Cabanzo-Arenas,D.F.;Ribero-Marulanda,S.;Llanes-Amaya,E.R.ValidityofthePatientHealthQuestionnaire-9(PHQ-9)for
depressionscreeninginadultprimarycareusersinBucaramanga,Colombia.Rev.Colomb.Psiquiatr.2021,50,11–21.[CrossRef]
[PubMed]
14. Calderón,M.;Gálvez-Buccollini,J.;Cueva,G.;Ordoñez,C.;Bromley,C.;Fiestas,F.ValidationofthePeruvianversionofthe
PHQ-9fordiagnosingdepression.Rev.Peru.Med.Exp.YSaludPública2012,29,578–579.[CrossRef][PubMed]
15. Saldivia, S.; Aslan, J.; Cova, F.; Vicente, B.; Inostroza, C.; Rincón, P. Propiedades psicométricas del PHQ-9 (Patient Health
Questionnaire)encentrosdeatenciónprimariadeChile.Rev.MédicaChile2019,147,53–60.[CrossRef]
16. Aslan,J.;Cova,F.;Saldivia,S.;Bustos,C.;Inostroza,C.;Rincón,P.;Ortiz,C.;Bühring,V.PsychometricPropertiesofthePatient
HealthQuestionnaire-9inElderlyChileanPrimaryCareUsers.Front.Psychiatry2020,11,555011.[CrossRef]
17. Miranda,C.A.C.;Scoppetta,O.FactorialstructureofthePatientHealthQuestionnaire-9asadepressionscreeninginstrumentfor
universitystudentsinCartagena,Colombia.PsychiatryRes.2018,269,425–429.[CrossRef]
18. López-Guerra,V.M.;López-Núñez,C.;Vaca-Gallegos,S.L.;Torres-Carrión,P.V.PsychometricPropertiesandFactorStructureof
thePatientHealthQuestionnaire-9asaScreeningToolforDepressionAmongEcuadorianCollegeStudents.Front.Psychol.2022,
13,813894.[CrossRef]
19. Huarcaya-Victoria,J.;De-Lama-Morán,R.;Quiros,M.;Bazán,J.;López,K.;Lora,D.PropiedadespsicométricasdelPatientHealth
Questionnaire(PHQ-9)enestudiantesdemedicinaenLima,Perú.Rev.Neuro-Psiquiatr.2020,83,72–78.[CrossRef]
20. Familiar,I.;Ortiz-Panozo,E.;Hall,B.;Vieitez,I.;Romieu,I.;Lopez-Ridaura,R.;Lajous,M.FactorstructureoftheSpanishversion
ofthePatientHealthQuestionnaire-9inMexicanwomen.Int.J.MethodsPsychiatr.Res.2015,24,74–82.[CrossRef]
21. Arrieta,J.;Aguerrebere,M.;Raviola,G.;Flores,H.;Elliott,P.;Espinosa,A.;Reyes,A.;Ortiz-Panozo,E.;Rodriguez-Gutierrez,E.G.;
Mukherjee,J.;etal.ValidityandutilityofthePatientHealthQuestionnaire(PHQ)-2andPHQ-9forscreeninganddiagnosisof
depressioninruralChiapas,Mexico:Across-sectionalstudy.J.Clin.Psychol.2017,73,1076–1090.[CrossRef]
22. Scoppetta,O.;Cassiani-Miranda,C.A.;Arocha-Díaz,K.N.;Cabanzo-Arenas,D.F.;Campo-Arias,A.Validityofthepatienthealth
questionnaire-2 (PHQ-2) for the detection of depression in primary care in Colombia. J. Affect. Disord. 2021, 278, 576–582.
[CrossRef][PubMed]
23. Caneo,C.;Toro,P.;Ferreccio,C.ValidityandPerformanceofthePatientHealthQuestionnaire(PHQ-2)forScreeningofDepression
inaRuralChileanCohort.CommunityMent.HealthJ.2020,56,1284–1291.[CrossRef][PubMed]
24. InstitutoNacionaldeEstadísticas. CaracterísticasSociodemográficasdelaInmigraciónInternacionalenChileCenso2017;Instituto
NacionaldeEstadísticas: Santiago,Chile,2018;Availableonline: http://www.censo2017.cl/descargas/inmigracion/181126
-sintesis.pdf(accessedon26October2022).
25. Salas-Wright,C.P.;Vaughn,M.G.;Goings,T.C.;Miller,D.P.;Schwartz,S.J.Immigrantsandmentaldisordersintheunitedstates:
Newevidenceonthehealthymigranthypothesis.PsychiatryRes.2018,267,438–445.[CrossRef]
26. Edwards,J.;Hu,M.;Thind,A.;Stranges,S.;Chiu,M.;Anderson,K.K.GapsinUnderstandingoftheEpidemiologyofMood
andAnxietyDisordersamongMigrantGroupsinCanada:ASystematicReview.Can.J.Psychiatry2019,64,595–606.[CrossRef]
[PubMed]
27. Markkula,N.;Lehti,V.;Gissler,M.;Suvisaari,J.Incidenceandprevalenceofmentaldisordersamongimmigrantsandnative
Finns:Aregister-basedstudy.Soc.PsychiatryPsychiatr.Epidemiol.2017,52,1523–1540.[CrossRef][PubMed]
28. DeWit,M.A.;Tuinebreijer,W.C.;Dekker,J.;Beekman,A.J.;Gorissen,W.H.;Schrier,A.C.;Penninx,B.W.;Komproe,I.H.;Verhoeff,
A.P.Depressiveandanxietydisordersindifferentethnicgroups:ApopulationbasedstudyamongnativeDutch,andTurkish,
MoroccanandSurinamesemigrantsinAmsterdam.Soc.PsychiatryPsychiatr.Epidemiol.2008,43,905–912.[CrossRef]
29. Bhugra,D.Migrationandmentalhealth.ActaPsychiatr.Scand.2004,109,243–258.[CrossRef]
30. Close,C.;Kouvonen,A.;Bosqui,T.;Patel,K.;O’Reilly,D.;Donnelly,M.Thementalhealthandwellbeingoffirstgeneration
migrants:Asystematic-narrativereviewofreviews.Glob.Health2016,12,47.[CrossRef]
31. Blukacz,A.;Cabieses,B.;Markkula,N.Inequitiesinmentalhealthandmentalhealthcarebetweeninternationalimmigrantsand
localsinChile:Anarrativereview.Int.J.EquityHealth2020,19,197.[CrossRef]
Int.J.Environ.Res.PublicHealth2022,19,13975 12of13
32. Pettersson,H.V.Designofmastersamplingframesandmastersamplesforhouseholdsurveysindevelopingcountries.InHousehold
SampleSurveysinDevelopingandTransitionCountries;DepartmentofEconomicandSocialAffairs:NewYork,NY,USA,2005.
33. InstitutoNacionaldeEstadísticas(INE).CensodePoblaciónyVivienda2017;InstitutoNacionaldeEstadísticas:Santiago,Chile,
2017;Availableonline:https://www.ine.cl/estadisticas/sociales/censos-de-poblacion-y-vivienda(accessedon21October2022).
34. Manea,L.;Gilbody,S.;McMillan,D.Optimalcut-offscorefordiagnosingdepressionwiththePatientHealthQuestionnaire
(PHQ-9):Ameta-analysis.CMAJ2012,184,E191–E196.[CrossRef]
35. Kroenke,K.;Spitzer,R.L.;Williams,J.B.;Löwe,B.ThePatientHealthQuestionnaireSomatic,Anxiety,andDepressiveSymptom
Scales:Asystematicreview.Gen.Hosp.Psychiatry2010,32,345–359.[CrossRef]
36. García-Campayo,J.;Zamorano,E.;Ruiz,M.A.;Pardo,A.;Pérez-Páramo,M.;López-Gómez,V.;Freire,O.;Rejas,J.Cultural
adaptationintoSpanishofthegeneralizedanxietydisorder-7(GAD-7)scaleasascreeningtool.HealthQual.LifeOutcomes2010,
8,8.[CrossRef][PubMed]
37. Robins,L.N.;Wing,J.;Wittchen,H.U.;Helzer,J.E.;Babor,T.F.;Burke,J.;Farmer,A.;Jablenski,A.;Pickens,R.;Regier,D.A.;etal.
TheCompositeInternationalDiagnosticInterview.AnepidemiologicInstrumentsuitableforuseinconjunctionwithdifferent
diagnosticsystemsandindifferentcultures.Arch.Gen.Psychiatry1988,45,1069–1077.[CrossRef][PubMed]
38. Cía,A.H.;Stagnaro,J.C.;AguilarGaxiola,S.;Vommaro,H.;Loera,G.;Medina-Mora,M.E.;Sustas,S.;Benjet,C.;Kessler,R.C.
Lifetimeprevalenceandage-of-onsetofmentaldisordersinadultsfromtheArgentineanStudyofMentalHealthEpidemiology.
Soc.PsychiatryPsychiatr.Epidemiol.2018,53,341–350.[CrossRef][PubMed]
39. MinisteriodeSalud(MINSAL).InformeEncuestaNacionaldeSalud2016–2017. SaludMental1: Trastornodelánimo: Depresióny
BipolaridadIyII;MinisteriodeSalud:Santiago,Chile,2018;Availableonline:http://epi.minsal.cl/wp-content/uploads/2021/0
8/Informe_Trastornos_del_Animo_ENS_2016_17.pdf(accessedon21October2022).
40. Vicente,B.;Kohn,R.;Rioseco,P.;Saldivia,S.;Levav,I.;Torres,S.Lifetimeand12-monthprevalenceofDSM-III-Rdisordersinthe
Chilepsychiatricprevalencestudy.Am.J.Psychiatry2006,163,1362–1370.[CrossRef]
41. Gómez-Restrepo,C.;Bohórquez,A.;PintoMasis,D.;GilLaverde,J.F.;RondónSepúlveda,M.;Díaz-Granados,N.Theprevalence
ofandfactorsassociatedwithdepressioninColombia.Rev.Panam.SaludPublica2004,16,378–386.[CrossRef]
42. Gómez-Restrepo,C.;TamayoMartínez,N.;Bohórquez,A.;Rondón,M.;MedinaRico,M.;Rengifo,H.;Bautisa,N.Depressionand
AnxietyDisordersandAssociatedFactorsintheAdultColombianPopulation,2015NationalMentalHealthSurvey.Rev.Colomb.
Psiquiatr.2016,45(Suppl.1),58–67.[CrossRef]
43. Posada-Villa,J.;Aguilar-Gaxiola,S.;Magaña,C.G.;Gómez,L.C.Prevalenciadetrastornosmentalesyusodeservicios:Resultados
preliminaresdelEstudioNacionaldeSaludMental.Colombia,2003.Rev.Colomb.Psiquiatr.2004,33,241–262.[CrossRef]
44. TorresdeGalvis,Y.;Agudelo-Martínez,A.;Sierra-Hincapié,G.;Salas-Zapata,C.Prevalenciadetrastornosmentalesenpoblación
generaldelmunicipiodeItagüí(Colombia),2012.CESMed.2014,28,49–60.
45. TorresdeGalvis,Y.;CastañoPérez,G.;SierraHincapié,G.;SalasZapata,C.;BareñoSilva,J.EstudiodeSaludMentalMedellín2019;
EditorialCES:Medellín,Colombia,2020.
46. TorresdeGalvis,Y.;RestrepoBernal,D.;CastañoPérez,G.;BareñoSilva,J.;SierraHincapié,G.;SalasZapata,C.;BuitragoSalazar,
C.EstudioPoblacionaldeSaludMentalSabaneta2018;EditorialCES:Medellín,Colombia,2018.
47. TorresdeGalvis,Y.;Restrepo,D.;Castaño,G.;Sierra,G.;Buitrago,C.;Carolina,C.;Bareño,J.EstudioPoblacionaldeSaludMental
Envigado2017;EditorialCES:Medellín,Colombia,2018.
48. Puac-Polanco,V.;Lopez-Soto,V.;Kohn,R.;Xie,D.;Richmond,T.;Branas,C.Previousviolenteventsandmentalhealthoutcomes
inGuatemala.Am.J.PublicHealth2015,105,764–771.[CrossRef]
49. Andrade,L.;Caraveo-Anduaga,J.J.;Berglund,P.;Bijl,R.V.;DeGraaf,R.;Vollebergh,W.;Dragomirecka,E.;Kohn,R.;Keller,M.;
Kessler,R.C.;etal.Theepidemiologyofmajordepressiveepisodes:ResultsfromtheInternationalConsortiumofPsychiatric
Epidemiology(ICPE)Surveys.Int.J.MethodsPsychiatr.Res.2003,12,3–21.[CrossRef][PubMed]
50. SalgadodeSnyder,V.;Díaz-Pérez,M.Lostrastornosafectivosenlapoblaciónrural=Affectivedisordersintheruralpopulation.
SaludMent.1999,22,68–74.
51. Slone,L.B.;Norris,F.H.;Murphy,A.D.;Baker,C.K.;Perilla,J.L.;Diaz,D.;Rodriguez,F.G.;GutiérrezRodriguezJde,J.Epidemiol-
ogyofmajordepressioninfourcitiesinMexico.Depress.Anxiety2006,23,158–167.[CrossRef][PubMed]
52. Fiestas,F.;Piazza,M.LifetimeprevalenceandageofonsetofmentaldisordersinPeru:ResultsoftheWorldMentalHealthStudy,
2005.Rev.Peru.Med.Exp.SaludPublica2014,31,39–47.
53. Felitti, V.J.; Anda, R.F.; Nordenberg, D.; Williamson, D.F.; Spitz, A.M.; Edwards, V.; Koss, M.P.; Marks, J.S. Relationship
ofchildhoodabuseandhouseholddysfunctiontomanyoftheleadingcausesofdeathinadults: TheAdverseChildhood
Experiences(ACE)Study.Am.J.Prev.Med.1998,14,245–258.[CrossRef]
54. Bland,J.M.;Altman,D.G.Cronbach’salpha.BMJ1997,314,572.[CrossRef][PubMed]
55. Hinkle,D.E.;Wiersma,W.;Jurs,S.G.AppliedStatisticsfortheBehavioralSciences;HoughtonMifflinCollegeDivision:Boston,MA,
USA,2003;Volume663.
56. Krause,J.S.;Bombardier,C.;Carter,R.E.Assessmentofdepressivesymptomsduringinpatientrehabilitationforspinalcord
injury:IsthereanunderlyingsomaticfactorwhenusingthePHQ?Rehabil.Psychol.2008,53,513.[CrossRef]
57. Richardson,E.J.;Richards,J.S.FactorstructureofthePHQ-9screenfordepressionacrosstimesinceinjuryamongpersonswith
spinalcordinjury.Rehabil.Psychol.2008,53,243–249.[CrossRef]
58. Bentler,P.M.Comparativefitindexesinstructuralmodels.Psychol.Bull.1990,107,238–246.[CrossRef]
Int.J.Environ.Res.PublicHealth2022,19,13975 13of13
59. Steiger,J.H.StructuralModelEvaluationandModification: AnIntervalEstimationApproach. Multivar. Behav. Res. 1990,25,
173–180.[CrossRef]
60. Hu,L.T.;Bentler,P.M.Cutoffcriteriaforfitindexesincovariancestructureanalysis:Conventionalcriteriaversusnewalternatives.
Struct.Equ.Model.AMultidiscip.J.1999,6,1–55.[CrossRef]
61. Mitchell,A.;Coyne,J.ScreeningforDepressioninClinicalPractice:AnEvidence-BasedGuide;OxfordUniversityPress:Oxford,UK,2009.
62. Hosmer,D.W.,Jr.;Lemeshow,S.;Sturdivant,R.X.AppliedLogisticRegression;JohnWiley&Sons:Hoboken,NJ,USA,2013;Volume398.
63. Staples,L.G.;Dear,B.F.;Gandy,M.;Fogliati,V.;Fogliati,R.;Karin,E.;Nielssen,O.;Titov,N.Psychometricpropertiesandclinical
utilityofbriefmeasuresofdepression,anxiety,andgeneraldistress:ThePHQ-2,GAD-2,andK-6.Gen.Hosp.Psychiatry2019,56,
13–18.[CrossRef][PubMed]
64. Baader,M.T.;Molina,F.J.L.;Venezian,B.S.;Rojas,C.C.;Farías,S.R.;Fierro-Freixenet,C.;Backenstrass,M.;Mundt,C.Validacióny
utilidaddelaencuestaPHQ-9(PatientHealthQuestionnaire)eneldiagnósticodedepresiónenpacientesusuariosdeatención
primariaenChile.Rev.Chil.Neuro-Psiquiatr.2012,50,10–22.[CrossRef]
65. Borghero,F.; Martínez,V.; Zitko,P.; Vöhringer,P.A.; Cavada,G.; Rojas,G.Tamizajedeepisodiodepresivoenadolescentes.
ValidacióndelinstrumentoPHQ-9.Rev.MédicaChile2018,146,479–486.[CrossRef][PubMed]
66. Quiñonez-Freire, C.; Vara, M.D.; Tomás, J.; Baños, R.PsychometricpropertiesoftheSpanishversionofthePatientHealth
Questionnaire-9inusersoftheEcuadorianpublichealthcaresystem.Rev.Latinoam.Psicol.2021,53,210–217.[CrossRef]
67. Hirschfeld,R.M.TheComorbidityofMajorDepressionandAnxietyDisorders:RecognitionandManagementinPrimaryCare.
Prim.CareCompanionJ.Clin.Psychiatry2001,3,244–254.[CrossRef]
68. Hanel,G.;Henningsen,P.;Herzog,W.;Sauer,N.;Schaefert,R.;Szecsenyi,J.;Löwe,B.Depression,anxiety,andsomatoform
disorders:Vagueordistinctcategoriesinprimarycare?Resultsfromalargecross-sectionalstudy.J.Psychosom.Res.2009,67,
189–197.[CrossRef]
69. Smith,M.L.;Sanchez,S.E.;Rondon,M.;Gradus,J.L.;Gelaye,B.ValidationofthePatientHealthQuestionnaire-9(PHQ-9)for
DetectingDepressionAmongPregnantWomeninLima,Peru.Curr.Psychol.2022,41,3797–3805.[CrossRef]
70. Krause,J.S.;Saunders,L.L.;Bombardier,C.;Kalpakjian,C.ConfirmatoryFactorAnalysisofthePatientHealthQuestionnaire-9:A
StudyoftheParticipantsFromtheSpinalCordInjuryModelSystems.PMR2011,3,533–540.[CrossRef]
71. Negeri,Z.F.;Levis,B.;Sun,Y.;He,C.;Krishnan,A.;Wu,Y.;Bhandari,P.M.;Neupane,D.;Brehaut,E.;Benedetti,A.;etal.Accuracy
ofthePatientHealthQuestionnaire-9forscreeningtodetectmajordepression: Updatedsystematicreviewandindividual
participantdatameta-analysis.BMJ2021,375,n2183.[CrossRef]
72. Araya, R.; Rojas, G.; Fritsch, R.; Acuña, J.; Lewis, G. Common mental disorders in Santiago, Chile: Prevalence and socio-
demographiccorrelates.Br.J.Psychiatry2001,178,228–233.[CrossRef][PubMed]
73. Piazza,M.;Fiestas,F.AnnualprevalenceofmentaldisordersanduseofmentalhealthservicesinPeru: ResultsoftheWorld
MentalHealthSurvey,2005.Rev.Peru.Med.Exp.SaludPublica2014,31,30–38.[PubMed]
74. Alegría, M.; Álvarez, K.; DiMarzio, K.ImmigrationandMentalHealth. Curr. Epidemiol. Rep. 2017, 4, 145–155. [CrossRef]
[PubMed]
75. Ikonte,C.O.;Prigmore,H.L.;Dawson,A.Z.;Egede,L.E.Trendsinprevalenceofdepressionandseriouspsychologicaldistressin
UnitedStatesimmigrantandnon-immigrantpopulations,2010–2016.J.Affect.Disord.2020,274,719–725.[CrossRef][PubMed]
76. Richardson,T.;Elliott,P.;Roberts,R.Therelationshipbetweenpersonalunsecureddebtandmentalandphysicalhealth: A
systematicreviewandmeta-analysis.Clin.Psychol.Rev.2013,33,1148–1162.[CrossRef]
77. Nelson,J.;Klumparendt,A.;Doebler,P.;Ehring,T.Childhoodmaltreatmentandcharacteristicsofadultdepression:Meta-analysis.
Br.J.Psychiatry2017,210,96–104.[CrossRef]
78. Giannelis,A.;Palmos,A.;Hagenaars,S.P.;Breen,G.;Lewis,C.M.;Mutz,J.Examiningtheassociationbetweenfamilystatusand
depressionintheUKBiobank.J.Affect.Disord.2021,279,585–598.[CrossRef]
